CellaVision AB (publ) (STO:CEVI)

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Americas Revenue	302.59M	301.25M	268.56M
Americas Revenue Growth	0.45%	12.17%	-14.30%
EMEA Revenue	319.70M	350.37M	334.27M
EMEA Revenue Growth	-8.75%	4.82%	20.60%
APAC Revenue	108.30M	107.35M	120.38M
APAC Revenue Growth	0.89%	-10.83%	38.75%
Revenue (Total)	730.59M	758.97M	723.22M
Revenue (Total) Growth	-3.74%	4.94%	6.78%

Revenue

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Instruments Revenue	410.79M	439.65M	407.17M
Instruments Revenue Growth	-6.56%	7.98%	7.02%
Reagents Revenue	149.98M	148.86M	140.54M
Reagents Revenue Growth	0.75%	5.91%	9.82%
Software & Other Revenue	169.82M	170.46M	175.50M
Software & Other Revenue Growth	-0.37%	-2.87%	3.94%
Revenue (Total)	730.59M	758.97M	723.22M
Revenue (Total) Growth	-3.74%	4.94%	6.78%

Key Performance Indicators

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Organic Growth	9.00%	7.00%

Updated Apr 24, 2026. Data Source: Fiscal.ai.